Navigation Links
Komen for the Cure Launches 'Presidential' Campaign
Date:9/26/2007

allenges the candidates to address three critical, commonsense goals: 1) More Research -- and better ways to ensure that critical advances in the laboratory reach patients; 2) Free Screening -- so that every low-income, uninsured, and underinsured woman in America has access to early detection and 3) Treatment for all -- to make sure that all women diagnosed with breast cancer have access to high quality treatment.

"New Hampshire voters play a special role is selecting the next President," said Rebecca Gray, volunteer and former President, VT-NH Affiliate of the Susan G. Komen for the Cure. "Let's use that unique opportunity -- and the power of millions of survivors and their loved ones who are affected by breast cancer -- to make the fight against this disease a top priority in the White House."

In the United States, a woman has about a 13 percent risk -- or one in eight -- of developing breast cancer in her lifetime. Low-income women are more likely to be diagnosed with late-stage breast cancer and are three times more likely to die from the disease.

About Susan G. Komen for the Cure

Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure, we have invested nearly $1 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. For more information about Susan G. Komen for the Cure, breast health or breast cancer, visit http://www.komen.org or call 1-800 I'M AWARE.


'/>"/>
SOURCE Susan G. Komen for the Cure
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Glaxo launches pills to help smokers quit in 7-12 weeks
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. Dr Reddy’s Laboratories launches Hyalosy
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. Scottish Health Minister Launches Organ Donor Plan
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
8. Pfizer Launches Viagra For Lung Disease In UK
9. PM Launches Healthcare Foundation For India
10. African Union Launches A Programme On Acceleration of HIV Prevention
11. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...all/ -- Heska Corporation,(Nasdaq: HSKA ) today... of,Security Analysts, 12th Annual Biotech and Sp...1177 Avenue of the Americas, 2nd Floor in New York...:35 a.m. Eastern Time (7:35 a.m.,Mountain Time) a...weeks,following the presentation through a link u...
(Date:11/21/2008)...ique to combat cancer, study says, , ,...archers have discovered that some cancer cells use...ight lead to new treatments that starve and kill t...ells in the body need to produce energy. They do t...uires oxygen. Compared with normal cells, tumor ce...
(Date:11/21/2008)...ire/ -- U.S. News & World Report and the Natio...BlueChoice(R) HealthPlan of South Carolina in the ...ished in U.S. News & World Report,s issue this...ks the nation,s best health plans based on clinica...ion scores. NCQA and U.S. News & World Report ...
(Date:11/21/2008)...production of neural stem cells , , FRID...mice, exercise appears to reverse the decline in t...h aging, Taiwanese researchers report. , This r...ave off aging appears to be due to exercise,s abil...or the production of new brain cells. , "As we...
Breaking Medicine News(10 mins):Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Exercise Keeps the Brain Young 2
...d villages have given birth to babies with eyesigh...med the air and water pollution //caused by coal m... Giridih district, around 200 km from here, were b...Saturday. The babies were admitted to an eye hospi...
...t outbreak of Avian Influenza in Pakistan. // In v...th-Western States bordering Pakistan were immediat...g areas especially to check informal/illegal trade...livestock and livestock products; intensify animal...
...ce and Medicine in Cricket (WCSMC), which is endor...as hosted in Barbados from the 4th to 7th April 20...ne consultant at the Manipal Hospital, Bangalore i... conference as a faculty from India. These scie...
... concerns of successive Australian governments, a ...on says //that the health of aborigines lags an ap...Aboriginal and Torres Strait Islander people have ...an their fellow countrymen on every indicator of h...
Other Medicine News:Health News:Women Deliver Babies With Eye Defects in Jharkhand Villages 2Health News:Steps To Prevent Out-Break Of Bird Flu 2Health News:Steps To Prevent Out-Break Of Bird Flu 3Health News:Cricket Science and Medicine Congress in Barbados 2Health News:Cricket Science and Medicine Congress in Barbados 3Health News:Cricket Science and Medicine Congress in Barbados 4Health News:Cricket Science and Medicine Congress in Barbados 5Health News:Aborigines Century Behind the Health of Colonizers, WHO Report 2
(Date:11/20/2008)...N, Nov. 20 PAREXEL Inter...global biopharmaceutical services provider, today ...ru to provide regulatory consulting and clinical r...u office, PAREXEL now has locations throughout fiv...rica, which also include Argentina, Brazil, Chile,...
(Date:11/19/2008)... , Study did not achieve statistical significa...FirstCall/ -- Pharmos Corporation (Nasdaq: PARS ...al trial of its topical NanoEmulsion (NE) drug del...thanolamine. , , The multi-center, randomiz...ated the safety and efficacy of the Company,s 3% D...
(Date:11/19/2008)...gers $5 Million Payment from Roche- , , MON...ory Pharmaceuticals Corp. (Nasdaq: MEMY ) today ... for its Phase 2 trial of R3487/MEM 3454, its lead...impairment associated with schizophrenia (CIAS). ...se 2 trial, triggering a $5.0 million payment from...
(Date:11/18/2008)...OWNE, Va., Nov. 18 Fort...hered at a November national forum to consider cut...blic health and national economy from outbreaks of...unced today. , , Among those innovations: ,...y American kitchen table that detects highly conta...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Chrysler Goes Holistic to Revolutionize Back Pain Care in the Workplace 11973 1Chrysler Goes Holistic to Revolutionize Back Pain Care in the Workplace 11973 2Chrysler Goes Holistic to Revolutionize Back Pain Care in the Workplace 11973 3New study shows extent of harmful human influences on global ecosystems 11971 1New study shows extent of harmful human influences on global ecosystems 11971 2Cell phone cancer link found by Tel Aviv University scientist 11969 1Cell phone cancer link found by Tel Aviv University scientist 11969 2Choking Game Turned Deadly for 82 Youths 11967 1Choking Game Turned Deadly for 82 Youths 11967 2Choking Game Turned Deadly for 82 Youths 11967 3
ACL 1000 is an affordable solution for low volume workloads, or as a backup analyzer. The test menu includes a variety of clotting assays, such as Lupus and APCR-V Leiden. The ACL 1000 also offers ba
The SYNCHRON CX4-S system consolidates DATs, TDMs and other esoteric tests in one workstation, targeted to the mid-size lab that processes 50-200 samples per day. Like all SYNCHRON CX super systems,
It takes powerful technology to increase laboratory efficiency and worker safety, and still lower costs. It takes the new SYNCHRON LX20 PRO, offering features that you will not find on any other chem
The leading fully automated system for plasma protein determinations. Third generation nephelometer combines reliability with highly cost-effective performance.
Medicine Products: